arrow
P

Peter C. Taylor

University of Oxford
H指数:85
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Losartan and prednisolone for post-COVID syndrome and cardiac inflammation: a randomized, double-blind, placebo-controlled trial

洛沙坦和泼尼松龙用于后COVID综合征和心脏炎症:一项随机、双盲、安慰剂对照试验

2026-07-300
OA
Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications

更正:Baricitinib在风险人群中特殊兴趣事件的安全性:来自风湿病学和皮肤病学适应症随机试验数据分析

2025-07-110
OAAI
Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints
2025-01-010
OAAI
DO HIGH RHEUMATOID FACTOR LEVELS IMPACT RESPONSE TO CERTOLIZUMAB PEGOL IN PATIENTS WITH INADEQUATELY CONTROLLED RHEUMATOID ARTHRITIS? A POST HOC ANALYSIS OF THE PHASE 3B REALISTIC TRIAL

高类风湿因子水平是否影响certolizumab pegol在控制不佳的类风湿关节炎患者中的应答?——REALISTIC三期B阶段试验的事后分析

2024-06-010
PRE